Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 21.42 USD -1.74% Market Closed
Market Cap: 191.5m USD

Wall Street
Price Targets

SMTI Price Targets Summary
Sanara Medtech Inc

Wall Street analysts forecast SMTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMTI is 41.82 USD with a low forecast of 36.36 USD and a high forecast of 48.3 USD.

Lowest
Price Target
36.36 USD
70% Upside
Average
Price Target
41.82 USD
95% Upside
Highest
Price Target
48.3 USD
125% Upside
Sanara Medtech Inc Competitors:
Price Targets
AP4
Riverstone Holdings Ltd
5% Upside
688253
Innovita Biological Technology Co Ltd
16% Upside
MED
Medartis Holding AG
3% Upside
ALGN
Align Technology Inc
17% Upside
ICUI
ICU Medical Inc
30% Upside
1066
Shandong Weigao Group Medical Polymer Co Ltd
27% Upside
301122
Caina Technology Co Ltd
4% Upside
HARTA
Hartalega Holdings Bhd
30% Upside

Revenue
Forecast

Revenue Estimate
Sanara Medtech Inc

For the last 13 years the compound annual growth rate for Sanara Medtech Inc's revenue is 33%. The projected CAGR for the next 3 years is 17%.

33%
Past Growth
17%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sanara Medtech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Sanara Medtech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMTI's stock price target?
Price Target
41.82 USD

According to Wall Street analysts, the average 1-year price target for SMTI is 41.82 USD with a low forecast of 36.36 USD and a high forecast of 48.3 USD.

What is Sanara Medtech Inc's Revenue forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Sanara Medtech Inc's revenue is 33%. The projected CAGR for the next 3 years is 17%.

Back to Top